About Nucliqbio
Nucliqbio is a company based in St. John's (Canada) founded in 2019 by Nikitha Kendyala and Purvikalyan Pallegar. Nucliqbio operates in a competitive market with competitors including Trace Genomics, Kallyope, AnimalBiome, Clinical Microbiomics and KoBioLabs, among others.
- Headquarter St. John's, Canada
- Founders Nikitha Kendyala, Purvikalyan Pallegar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$81.56 K (USD), Grant
Dec 29, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nucliqbio
Unlock access to complete
Unlock access to complete
Funding Insights of Nucliqbio
Investors in Nucliqbio
Nucliqbio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Canadian Space Agency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canadian space agency focused on social and economic benefits
|
Locked | Locked | Locked |
Investor details for Nucliqbio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nucliqbio
Investment portfolio details for Nucliqbio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nucliqbio
Detailed financials for Nucliqbio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nucliqbio Comparisons
Peer comparison for Nucliqbio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nucliqbio
Nucliqbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trace Genomics, Kallyope, AnimalBiome, Clinical Microbiomics and KoBioLabs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| Locked | Locked | Locked |
The gut-brain axis is explored for therapeutic and nutritional innovations.
|
|
| Locked | Locked | Locked |
Animal microbiome diagnostics services for pet care are offered.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
Microbiome therapeutics, diagnostics, and medicinal foods are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal complications are developed by Palisade Bio.
|
Detailed competitors of Nucliqbio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nucliqbio
Complete news archive for Nucliqbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nucliqbio
Nucliqbio was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Nucliqbio is headquartered in St. John's, Canada. It is registered at St. John's, Newfoundland And Labrador, Canada.
Nikitha Kendyala is the current CEO of Nucliqbio. They have also founded this company.
Nucliqbio was founded in 2019 in St. Johns, Canada, within the biotechnology sector. Focus is placed on developing therapeutic solutions through metagenomics and the gut microbiome to address intestinal conditions, including irritable bowel syndrome and inflammatory bowel disease. Operations center on drug creation for gut-related treatments, with research conducted in a Canadian base to support advancements in microbiome-based therapies.
Nucliqbio's top competitors include Trace Genomics, Kallyope and AnimalBiome.
Nucliqbio has 1 investor. Key investors include Canadian Space Agency.